Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'abciximab' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 223 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Paradiso-Hardy, FL; Madan, M; Radhakrishnan, S; Hurden, S; Cohen, EA
      Severe thrombocytopenia possibly related to readministration of eptifibatide

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    2. Moustapha, A; Assali, AR; Sdringola, S; Smalling, RW
      Microcoil embolization for coronary artery perforation

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    3. de la Serna, FA; Tolleson, TR; Crowley, JJ; Stack, RS; Zidar, JP
      Intra-arterial thrombolysis (reteplase) and reopro for subacute thrombosisof the distal aorta accomplished by radial arterial access: The radial-kissing-thrombolytic technique

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    4. Gibson, CM; Kirtane, AJ; Murphy, SA; Marble, SJ; de Lemos, JA; Antman, EM; Braunwald, E
      Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarction

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    5. Reddy, MS; Carmody, TJ; Kereiakes, DJ
      Severe delayed thrombocytopenia associated with abciximab (ReoPro) therapy

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    6. Lee, DP; Lo, S; Herity, NA; Ward, M; Yeung, AC
      Utility of mechanical rheolysis as an adjunct to rescue angioplasty and platelet inhibition in acute myocardial infarction and cardiogenic shock: A case report

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    7. Khan, MA; Liu, MW; Chio, FL; Yates, VB; Chapman, GD; Misra, VK; Sweeney, A; Dean, LS
      Effect of abciximab on cardiac enzyme elevation after transluminal extraction atherectomy (TEC) in high-risk saphenous vein graft lesions: Comparisonwith a historical control group

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    8. Montalescot, G; Choussat, R; Collet, JP
      Glycoprotein IIb/IIIa receptors and primary stenting in acute myocardial infarction

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    9. Antman, EM; de Lemos, JA; Braunwald, E
      Epicardial flow and myocardial reperfusion following abciximab and low-dose thrombolytic therapy for acute myocardial infarction

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    10. Hamm, CW
      GP IIb/IIIa receptor antagonists in unstable angina: troponin level-based patient selection

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    11. Neumann, FJ
      Optimization of microvascular reperfusion in acute myocardial infarction

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    12. Herrmann, HC; Li, RH; Ohman, EM
      Facilitated percutaneous coronary intervention: results from the SPEED trial

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    13. Manoharan, G; Adgey, AAJ
      Glycoprotein IIb/IIIa inhibitors and acute coronary syndromes: summary report of the full submission to NICE, and beyond

      HEART
    14. Vaisman, D; Ferguson, JJ
      Therapeutic potential of GP IIb/IIIa receptor antagonists in acute myocardial infarction

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    15. Abulencia, JP; Tien, N; McCarty, OJT; Plymire, D; Mousa, SA; Konstantopoulos, K
      Comparative antiplatelet efficacy of a novel, nonpeptide GPIIb/IIIa antagonist (XV454) and abciximab (c7E3) in flow models of thrombosis

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    16. Burgess, JK
      Molecular mechanisms of drug-induced thrombocytopenia

      CURRENT OPINION IN HEMATOLOGY
    17. Sreeram, GM; Sharma, AD; Slaughter, TF
      Platelet glycoprotein IIb/IIIa antagonists: Perioperative implications

      JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
    18. Benenati, J; Shlansky-Goldberg, R; Meglin, A; Seidl, E
      Thrombolytic and antiplatelet therapy in peripheral vascular disease with use of reteplase and/or abciximab - The SCVIR Consultants' Conference; May 22, 2000; Orlando, FL

      JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    19. Fontaine, AB; Borsa, JJ; Dos Passos, S; Hoffer, EK; Bloch, RD; Starr, F; So, C
      Evaluation of local abciximab delivery from the surface of a polymer-coated covered stent: In vivo canine studies

      JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    20. Bogousslavsky, J; Leclerc, JR
      Platelet glycoprotein IIb/IIIa blockade in acute ischemic stroke

      CEREBROVASCULAR DISEASES
    21. Sherman, DG
      Antithrombotic therapy in the acute phase: New approaches

      CEREBROVASCULAR DISEASES
    22. Devuyst, G; Bogousslavsky, J
      Recent progress in drug treatment for acute ischemic stroke

      CEREBROVASCULAR DISEASES
    23. Grubitzsch, H; Wollert, HG; Eckel, L
      Emergency coronary artery bypass grafting: does excessive preoperative anticoagulation increase bleeding complications and transfusion requirements?

      CARDIOVASCULAR SURGERY
    24. Holmes, MB; Kabbani, SS; Terrien, CM; Watkins, MW; Sobel, BE; Schneider, DJ
      Quantification by flow cytometry of the efficacy of and interindividual variation of platelet inhibition induced by treatment with tirofiban and abciximab

      CORONARY ARTERY DISEASE
    25. Lucore, CL; Trask, RV; Mishkel, GJ; Rocha-Singh, KJ; Shelton, ME; Mikell, FL; Ligon, RW
      Impact of abciximab and coronary stenting on outcomes and costs of percutaneous coronary interventions in a community hospital

      CORONARY ARTERY DISEASE
    26. Haase, KK; Latsch, A; Suselbeck, T; Muth, N; Pfleger, S; Baumbach, A; Borggrefe, M
      Efficacy of eptifibatide for treatment of severe dissections following percutaneous transluminal coronary angioplasty (PTCA) in small coronary arteries

      PERFUSION
    27. Matzdorff, AC; Kuhnel, G; Kemkes-Matthes, B; Voss, R
      Comparison of GP IIB/IIIA inhibitors and their activity as measured by aggregometry, flow cytometry, single platelet counting, and the rapid plateletfunction analyzer

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    28. Mukherjee, D; Chew, DP; Robbins, M; Yadav, JS; Raymond, RE; Moliterno, DJ
      Clinical application of procedural platelet monitoring during percutaneouscoronary intervention among patients at increased bleeding risk

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    29. Sallach, JA; Greenbaum, AB
      Glycoprotein IIb/IIIa inhibition as an adjunct to rescue angioplasty afterfailed fibrinolysis

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    30. Chew, DP; Moliterno, DJ
      GP IIb/IIIa inhibitors in coronary artery disease management: What the latest trials tell us

      CLEVELAND CLINIC JOURNAL OF MEDICINE
    31. Lapp, H; Krakau, I; Wolfertz, J; Ketteler, T; Ziegler, G; Boerrigter, G; Gulker, H
      Rescue-PTCA in acute myocardial infarction. Acute and long-term results

      MEDIZINISCHE KLINIK
    32. Philippe, F; Lacombe, C; Bucherer, C; Drobinski, G; Montalescot, G; Thomas, D
      Whole blood viscosity measurement in acute myocardial infarction: feasability and significance

      JOURNAL DES MALADIES VASCULAIRES
    33. Christou, I; Burgin, WS; Alexandrov, AV; Grotta, JC
      Arterial status after intravenous TPA therapy for ischaemic stroke. A needfor further interventions

      INTERNATIONAL ANGIOLOGY
    34. Rossi, F; Rossi, E; Pareti, FI; Colli, S; Tremoli, E; Gallo, L
      In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion

      HAEMATOLOGICA
    35. Schror, K
      Pathophysiology of platelet activation and pharmacology of GPIIb/IIIa antagonists

      HERZ
    36. Marques, JA; George, JK; Smith, IJ; Bhakta, V; Sheffield, WP
      A barbourin-albumin fusion protein that is slowly cleared in vivo retains the ability to inhibit platelet aggregation in vitro

      THROMBOSIS AND HAEMOSTASIS
    37. Coller, BS
      Anti-GPIIb/IIIa drugs: Current strategies and future directions

      THROMBOSIS AND HAEMOSTASIS
    38. Graff, J; Andries, D; Elsner, M; Westrup, D; Bassus, S; Franz, N; Klinkhardt, U; Harder, S
      Platelet CD62 expression and PDCFAB secretion in patients undergoing PTCA and treatment with abciximab

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    39. Heras, M
      Should treatment with glycoprotein IIa/IIIb receptor blocker be controlledin patients undergoing PCI?

      REVISTA ESPANOLA DE CARDIOLOGIA
    40. Zwart-van Rijkom, JEF; van Hout, BA
      Cost-efficacy in interventional cardiology - Results from the EPISTENT study

      EUROPEAN HEART JOURNAL
    41. McFadden, EP
      Fibrinolysis and stenting in acute myocardial infarction: newlyweds destined for a 'menage a trois'?

      EUROPEAN HEART JOURNAL
    42. Ng, PP; Phatouros, CC; Khangure, MS
      Use of glycoprotein IIb-IIIa inhibitor for a thromboembolic complication during Guglielmi detachable coil treatment of an acutely ruptured aneurysm

      AMERICAN JOURNAL OF NEURORADIOLOGY
    43. Salter, JW; Krieglstein, CF; Issekutz, AC; Granger, DN
      Platelets modulate ischemia/reperfusion-induced leukocyte recruitment in the mesenteric circulation

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    44. Swanson, N; Hogrefe, K; Lloyd, AS; Gershlick, A
      Current perspectives on British use of adjunctive therapies during coronary interventions

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    45. Zwart-van Rijkom, JEF; Klungel, OH; Leufkens, HGM; Broekmans, AW; Schrijver-van Velthoven, S; Umans, VA
      Costs and effects of combining stenting and abciximab (ReoPro (R)) in daily practice

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    46. Fry, ETA
      Glycoprotein IIb/IIIa inhibitors and low-molecular-weight heparins: A combined role in coronary interventions?

      CLINICAL CARDIOLOGY
    47. Cho, GY; Lee, CW; Hong, MK; Kang, DH; Song, JK; Kim, JJ; Park, SW; Park, SJ
      Rescue use of abciximab improves regional left ventricular function after early incomplete reperfusion in acute myocardial infarction

      CLINICAL CARDIOLOGY
    48. Truong, KM; Amankwa, K; Kucukarslan, S
      Platelet glycoprotein IIb/IIIa-receptor inhibitors in patients with acute coronary syndromes or undergoing percutaneous coronary interventions: A review

      CLINICAL THERAPEUTICS
    49. Cohen, M
      Glycoprotein IIb/IIIa receptor blockers in acute coronary syndromes: GustoIV-ACS

      LANCET
    50. Mousa, SA; Forsythe, MS
      Comparison of the effect of different platelet GPIIb/IIa antagonists on the dynamics of platelet/fibrin-mediated clot strength induced using thromboelastography

      THROMBOSIS RESEARCH
    51. Peter, K; Schwarz, M; Nordt, T; Bode, C
      Intrinsic activating properties of GP IIb/IIIa blockers

      THROMBOSIS RESEARCH
    52. Ross, AM
      Combination therapies to enhance reperfusion in acute myocardial infarction

      THROMBOSIS RESEARCH
    53. Haumer, M; Atteneder, M; Ahmadi, R; Schillinger, M; Minar, E
      Coadministration of low-dose urokinase and abciximab in thrombolysis for lower limb ischemia - A safety study

      THROMBOSIS RESEARCH
    54. Harder, S; Klinkhardt, U; Graff, J; Westrup, D; Kirchmaier, CM; Glusa, E; Mascelli, MA; Marciniak, SJ; Just, A; Losche, W; Breddin, HK
      In vitro dose response to different GPIIb/IIIa-antagonists: Inter-laboratory comparison of various platelet function tests

      THROMBOSIS RESEARCH
    55. Kageyama, S; Yamamoto, H; Nakazawa, H; Yoshimoto, R
      Anti-human vWF monoclonal antibody, AJvW-2 fab, inhibits repetitive coronary artery thrombosis without bleeding time prolongation in dogs

      THROMBOSIS RESEARCH
    56. Wu, CH; Chen, YC; Hsiao, G; Lin, CH; Liu, CM; Sheu, JR
      Mechanisms involved in the inhibition of neointimal hyperplasia by abciximab in a rat model of balloon angioplasty

      THROMBOSIS RESEARCH
    57. Kimura, K; Tsukahara, K; Usui, T; Okuda, J; Kitamura, Y; Kosuge, M; Sano, T; Tohyama, S; Yamanaka, O; Yoshii, Y; Umemura, S
      Low-dose tissue plasminogen activator followed by planned rescue angioplasty reduces time to reperfusion for acute myocardial infarction treated at community hospitals

      JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    58. Balachandran, KP; Oldroyd, KG
      Free wall rupture following rescue angioplasty and intravenous abciximab for failed thrombolysis

      SCOTTISH MEDICAL JOURNAL
    59. Chew, DP; Roffi, M; Topol, EJ
      Intravenous glycoprotein IIb/IIIa inhibition in non-ST segment elevation acute coronary syndromes

      PROGRESS IN CARDIOVASCULAR DISEASES
    60. Fintel, DJ
      From bench to bedside - GP IIb-IIIa inhibitors

      NEUROLOGY
    61. Bogousslavsky, J; Leclerc, JR
      Platelet glycoprotein IIb/IIIa antagonists for acute ischemic stroke

      NEUROLOGY
    62. Doggrell, SA
      Clinical trials with glycoprotein IIB/IIIA antagonists - No benefit without bleeding?

      DRUGS OF TODAY
    63. Kalra, S; Bell, MR; Rihal, CS
      Alveolar hemorrhage as a complication of treatment with abciximab

      CHEST
    64. Sabatine, MS; Braunwald, E
      Will diabetes save the platelet blockers?

      CIRCULATION
    65. Roffi, M; Chew, DP; Mukherjee, D; Bhatt, DL; White, JA; Heeschen, C; Hamm, CW; Moliterno, DJ; Califf, RA; White, HD; Kleiman, NS; Theroux, P; Topol, EJ
      Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with Non-ST-segment-elevation acute coronary syndromes

      CIRCULATION
    66. Armstrong, PW; Collen, D
      Fibrinolysis for acute myocardial infarction - Current status and new horizons for pharmacological reperfusion, part 2

      CIRCULATION
    67. Gibson, CM; de Lemos, JA; Murphy, SA; Marble, SJ; McCabe, CH; Cannon, CP; Antman, EM; Braunwald, E
      Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction - A TIMI 14 substudy

      CIRCULATION
    68. Steinhubl, SR; Talley, JD; Braden, GA; Tcheng, JE; Casterella, PJ; Moliterno, DJ; Navetta, FI; Berger, PB; Popma, JJ; Dangas, G; Gallo, R; Sane, DC; Saucedo, JF; Jia, G; Lincoff, AM; Theroux, P; Holmes, DR; Teirstein, PS; Kereiakes, DJ
      Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention - Results of the GOLD (AU-Assessing Ultegra) multicenter study

      CIRCULATION
    69. Chew, DP; Bhatt, DL; Sapp, S; Topol, EJ
      Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists -A meta-analysis of phase III multicenter randomized trials

      CIRCULATION
    70. Collet, JP; Montalescot, G; Lesty, C; Mishal, Z; Soria, J; Choussat, R; Drobinski, G; Soria, C; Pinton, P; Barragan, P; Thomas, D
      Effects of abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention

      CIRCULATION
    71. Osende, JI; Fuster, V; Lev, EI; Shimbo, D; Rauch, U; Marmur, JD; Richard, M; Varon, D; Badimon, JJ
      Testing platelet activation with a shear-dependent platelet function test versus aggregation-based tests - Relevance for monitoring long-term glycoprotein IIb/IIIa inhibition

      CIRCULATION
    72. Butenas, S; Cawthern, KM; van't Veer, C; DiLorenzo, ME; Lock, JB; Mann, KG
      Antiplatelet agents in tissue factor-induced blood coagulation

      BLOOD
    73. Waters, JH; Anthony, DG; Gottlieb, A; Sprung, J
      Bleeding in a patient receiving platelet aggregation inhibitors

      ANESTHESIA AND ANALGESIA
    74. Resnic, FS; Blake, GJ; Ohno-Machado, L; Selwyn, AP; Popma, JJ; Rogers, C
      Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors

      AMERICAN JOURNAL OF CARDIOLOGY
    75. Hongo, RH; Brent, BN
      Association of eptifibatide and acute profound thrombocytopenia

      AMERICAN JOURNAL OF CARDIOLOGY
    76. Singh, M; Berger, PB; Ting, HH; Rihal, CS; Wilson, SH; Lennon, RJ; Reeder, GS; Bresnahan, JF; Holmes, DR
      Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (The Mayo Clinic experience)

      AMERICAN JOURNAL OF CARDIOLOGY
    77. Cutlip, DE; Cove, CJ; Irons, D; Kalaria, V; Le, MM; Cronmiller, H; Caufield, L; Pomerantz, RM; Ling, FS
      Emergency room administration of eptifibatide before primary angioplasty for ST elevation acute myocardial infarction and its effect on baseline coronary flow and procedure outcomes

      AMERICAN JOURNAL OF CARDIOLOGY
    78. Lam, W; Gill, JB; Trask, RV; Mallavarapu, CT; Rocha-Singh, KJ; Mikell, FL; Mishkel, GJ; Mayer, SA; Aguirre, FV; Yakel, D; Steen, MS; Kacich, RL; Shelton, ME; Chaitman, BR; Stocke, K; Katholi, R; Pianfetti, L; Tatum, M; McMillan, S; Ligon, RW; Holloway, C; Cohen, DJ; Staten, N; Laswell, K; Sullivan, P; Rothert, T; Page, L; Brooks, M; Entwistle, K; Drew, D
      Comparative 30-day economic and clinical outcomes of platelet glycoproteinIIb/IIIa inhibitor use during elective percutaneous coronary intervention:Prairie ReoPro Versus Integrilin Cost Evaluation (PRICE) Trial

      AMERICAN HEART JOURNAL
    79. Santoro, GM; Bolognese, L
      Coronory stenting and platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction

      AMERICAN HEART JOURNAL
    80. Madan, M; Berkowitz, SD; Christie, DJ; Jennings, LK; Smit, AC; Sigmon, KN; Glazer, S; Tcheng, JE
      Rapid assessment of glycoprotein IIb/IIIa blockade with the platelet function analyzer PFA-100 during percutaneous coronary intervention

      AMERICAN HEART JOURNAL
    81. Assali, AR; Moustapha, A; Sdringola, S; Rihner, M; Smalling, RW
      Successful treatment of coronary artery perforation in an abciximab-treated patient by microcoil embolization

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    82. Velianou, JL; Strauss, BH; Kreatsoulas, C; Pericak, D; Natarajan, MK
      Evaluation of the role of abciximab (Reopro) as a rescue agent during percutaneous coronary interventions: In-hospital and six-month outcomes

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    83. Dillon, WC; Eckert, GJ; Dillon, JC; Ritchie, ME
      Incidence of thrombocytopenia following coronary stent placement using abciximab plus clopidogrel or ticlopidine

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    84. Marti, V; Romeo, I; Garcia, J; Guiteras, P; Aminian, N; Auge, JM
      Combined therapeutic strategy for multiple coronary thromboemboli

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    85. Vahdat, B; Canavy, I; Fourcade, L; Garcia, E; Quilici, J; Bonnet, JL; Bory, M
      Fatal cerebral hemorrhage and severe thrombocytopenia during abciximab treatment

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    86. Ali, A; Patil, S; Grady, KJ; Schreiber, TL
      Diffuse alveolar hemorrhage following administration of tirofiban or abciximab: A nemesis of platelet glycoprotein IIb/IIIa inhibitors

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    87. Kupatt, C; Habazettl, H; Hanusch, P; Wichels, R; Hahnel, D; Becker, BF; Boekstegers, P
      c7E3Fab reduces postischemic leukocyte-thrombocyte interaction mediated byfibrinogen - Implications for myocardial reperfusion injury

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    88. Bishara, AI; Hagmeyer, KO
      Acute profound thrombocytopenia following abciximab therapy

      ANNALS OF PHARMACOTHERAPY
    89. Mathis, AS
      Newer antithrombotic strategies in the initial management of non-ST-Segment elevation acute coronary syndromes

      ANNALS OF PHARMACOTHERAPY
    90. Sesana, M; Vaghetti, M; Albiero, R; Corvaja, N; Martini, G; Sivieri, G; Colombo, A
      Effectiveness and complications of vascular access closure devices after interventional procedures

      JOURNAL OF INVASIVE CARDIOLOGY
    91. Arjomand, H; Mascarenhas, DAN
      Combination of abciximab with primary stenting in patients with acute myocardial infarction: A community hospital experience

      JOURNAL OF INVASIVE CARDIOLOGY
    92. Anderson, HV
      Platelet GP IIb/IIIa inhibition in myocardial infarction treated by coronary stenting: Ready for prime time

      JOURNAL OF INVASIVE CARDIOLOGY
    93. Desai, M; Lucore, CL
      Uneventful use of tirofiban as an adjunct to coronary stenting in a patient with a history of abciximab-associated thrombocytopenia 10 months earlier

      JOURNAL OF INVASIVE CARDIOLOGY
    94. Fuchs, S; Kornowski, R; Mehran, R; Gruberg, L; Satler, LF; Pichard, AD; Kent, KM; Stone, GW; Leon, MB
      Clinical outcomes following "rescue" administration of abciximab in patients undergoing percutaneous coronary angioplasty

      JOURNAL OF INVASIVE CARDIOLOGY
    95. Kandzari, DE; Tcheng, JE; Harrington, RA; Sketch, MH
      "Rescue"' platelet GP IIb/IIIa inhibitor therapy in percutaneous coronary intervention: Bailing out of a sunken ship

      JOURNAL OF INVASIVE CARDIOLOGY
    96. Coto, H
      Platelet receptor glycoprotein IIb/IIIa inhibition with eptifibatide in a patient with thrombocytopenia after treatment with abciximab

      JOURNAL OF INVASIVE CARDIOLOGY
    97. Del Campo, C; Zelman, R
      Successful non-operative management of right coronary artery perforation during percutaneous coronary intervention in a patient receiving abciximab and aspirin

      JOURNAL OF INVASIVE CARDIOLOGY
    98. Weksler, BB
      Antiplatelet agents in stroke prevention - Combination therapy: Present and future

      CEREBROVASCULAR DISEASES
    99. Steinhubl, SR
      Assessing the optimal level of platelet inhibition with GPIIb/IIIa inhibitors in patients undergoing coronary intervention. Rationale and design of the GOLD study

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    100. Jafary, FH; Kimmelstiel, CD
      Antiplatelet therapy in interventional cardiology: II. Glycoprotein IIb/IIIa inhibitors

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/02/20 alle ore 11:17:44